Comment on Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression (vol 43, pg79, 2023)-MedSci.cn - 梅斯（MedSci）

Comment on Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression (vol 43, pg79, 2023)

Wilkowska, A; Cubala, WJ

Wilkowska, A (通讯作者)，Med Univ Gdansk, Fac Med, Dept Psychiat, ul Smoluchowskiego 17, PL-80214 Gdansk, Poland.

CLINICAL DRUG INVESTIGATION, 2023; 43 (1): 81

科室
- - 订阅+
  - 更多科室
工具
服务